10/14/09
11:19 AM
Hello Jodi Limacher,
Thank you for your comments on linking dietary chromium to healthy blood sugar levels. A well respected study out of China and many others support your conclusions. (Anderson RA, et al. Elevated intakes of supplemental chromium improve glucose and insulin variables with type 2 diabetes. Diabetes 1997;46:1786-91)
I'm Ken Hampshire, the formulator of DiaMetrix and I hope you will allow me to make some corrections to your comments regarding the clinical study done on DiaMetrix.
In 2007, DiaMetrix was subjected to the most rigorous study of any dietary supplement within the industry: a gold-standard, 100-person, placebo controlled, double blind, fully randomized human clinical study.
Study participants were chronic type 2 diabetics, between 23 and 50 years old, 47 men and 53 women, and were taking no pharmaceutical remedies for their blood sugar control. They were instructed to make no changes to their diet, activity level or fluid intake for the duration of the study.
In short, this study met all requirements of a bona fide research
study. Our goal was to measure the effect of DiaMetrix on fasting blood sugar levels, A1c, cholesterol, triglycerides, blood pressure, weight loss, and other biological markers.
A complete description of the study, and the 90-day results, have been available for download for over a year on our website. I hope my efforts today have not violated or infringed upon the terms and agreement of the dLife policies.
My thanks to you and dLife for your excellent work and advice.
Ken Hampshire
FLAG
10/13/09
01:58 PM
Hello Jodi Limacher,
Thank you for your comments on linking dietary chromium to healthy blood sugar levels. A well respected study out of China and many others support your conclusions. (Anderson RA, et al. Elevated intakes of supplemental chromium improve glucose and insulin variables with type 2 diabetes. Diabetes 1997;46:1786-91)
I'm Ken Hampshire, the formulator of DiaMetrix and I hope you will allow me to make some corrections to your comments regarding the clinical study done on DiaMetrix.
In 2007, DiaMetrix was subjected to the most rigorous study of any dietary supplement within the industry: a gold-standard, 100-person, placebo controlled, double blind, fully randomized human clinical study.
Study participants were chronic type 2 diabetics, between 23 and 50 years old, 47 men and 53 women, and were taking no pharmaceutical remedies for their blood sugar control. They were instructed to make no changes to their diet, activity level or fluid intake for the duration of the study.
In short, this study met all requirements of a bona fide research
study. Our goal was to measure the effect of DiaMetrix on fasting blood sugar levels, A1c, cholesterol, triglycerides, blood pressure, weight loss, and other biological markers.
A complete description of the study, and the 90-day results, have been available for download for over a year on our website. I hope my efforts today have not violated or infringed upon the terms and agreement of the dLife policies.
My thanks to you and dLife for your excellent work and advice.
Ken Hampshire
FLAG
10/13/09
01:57 PM
Hello Jodi Limacher,
Thank you for your comments on linking dietary chromium to healthy blood sugar levels. A well respected study out of China and many others support your conclusions. (Anderson RA, et al. Elevated intakes of supplemental chromium improve glucose and insulin variables with type 2 diabetes. Diabetes 1997;46:1786-91)
I'm Ken Hampshire, the formulator of DiaMetrix and I hope you will allow me to make some corrections to your comments regarding the clinical study done on DiaMetrix.
In 2007, DiaMetrix was subjected to the most rigorous study of any dietary supplement within the industry: a gold-standard, 100-person, placebo controlled, double blind, fully randomized human clinical study.
Study participants were chronic type 2 diabetics, between 23 and 50 years old, 47 men and 53 women, and were taking no pharmaceutical remedies for their blood sugar control. They were instructed to make no changes to their diet, activity level or fluid intake for the duration of the study.
In short, this study met all requirements of a bona fide research
study. Our goal was to measure the effect of DiaMetrix on fasting blood sugar levels, A1c, cholesterol, triglycerides, blood pressure, weight loss, and other biological markers.
A complete description of the study, and the 90-day results, have been available for download for over a year on our website. I hope my efforts today have not violated or infringed upon the terms and agreement of the dLife policies.
My thanks to you and dLife for your excellent work and advice.
Ken Hampshire
FLAG